180 related articles for article (PubMed ID: 10916682)
1. Triosephosphate isomerase deficiency: historical perspectives and molecular aspects.
Schneider AS
Baillieres Best Pract Res Clin Haematol; 2000 Mar; 13(1):119-40. PubMed ID: 10916682
[TBL] [Abstract][Full Text] [Related]
2. Missense variant in TPI1 (Arg189Gln) causes neurologic deficits through structural changes in the triosephosphate isomerase catalytic site and reduced enzyme levels in vivo.
Roland BP; Richards KR; Hrizo SL; Eicher S; Barile ZJ; Chang TC; Savon G; Bianchi P; Fermo E; Ricerca BM; Tortorolo L; Vockley J; VanDemark AP; Palladino MJ
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2257-2266. PubMed ID: 31075491
[TBL] [Abstract][Full Text] [Related]
3. Triosephosphate isomerase deficiency: facts and doubts.
Orosz F; Oláh J; Ovádi J
IUBMB Life; 2006 Dec; 58(12):703-15. PubMed ID: 17424909
[TBL] [Abstract][Full Text] [Related]
4. Evidence for founder effect of the Glu104Asp substitution and identification of new mutations in triosephosphate isomerase deficiency.
Arya R; Lalloz MR; Bellingham AJ; Layton DM
Hum Mutat; 1997; 10(4):290-4. PubMed ID: 9338582
[TBL] [Abstract][Full Text] [Related]
5. Triosephosphate isomerase I170V alters catalytic site, enhances stability and induces pathology in a Drosophila model of TPI deficiency.
Roland BP; Amrich CG; Kammerer CJ; Stuchul KA; Larsen SB; Rode S; Aslam AA; Heroux A; Wetzel R; VanDemark AP; Palladino MJ
Biochim Biophys Acta; 2015 Jan; 1852(1):61-9. PubMed ID: 25463631
[TBL] [Abstract][Full Text] [Related]
6. Triosephosphate isomerase deficiency: Effect of F240L mutation on enzyme structure.
Romero JM
Arch Biochem Biophys; 2020 Aug; 689():108473. PubMed ID: 32585311
[TBL] [Abstract][Full Text] [Related]
7. Triosephosphate isomerase deficiency: a patient with Val231Met mutation.
Serdaroglu G; Aydinok Y; Yilmaz S; Manco L; Ozer E
Pediatr Neurol; 2011 Feb; 44(2):139-42. PubMed ID: 21215915
[TBL] [Abstract][Full Text] [Related]
8. Structural and Genetic Studies Demonstrate Neurologic Dysfunction in Triosephosphate Isomerase Deficiency Is Associated with Impaired Synaptic Vesicle Dynamics.
Roland BP; Zeccola AM; Larsen SB; Amrich CG; Talsma AD; Stuchul KA; Heroux A; Levitan ES; VanDemark AP; Palladino MJ
PLoS Genet; 2016 Mar; 12(3):e1005941. PubMed ID: 27031109
[TBL] [Abstract][Full Text] [Related]
9. The relationship of the -5, -8, and -24 variant alleles in African Americans to triosephosphate isomerase (TPI) enzyme activity and to TPI deficiency.
Schneider A; Forman L; Westwood B; Yim C; Lin J; Singh S; Beutler E
Blood; 1998 Oct; 92(8):2959-62. PubMed ID: 9763583
[TBL] [Abstract][Full Text] [Related]
10. Evidence of a triosephosphate isomerase non-catalytic function crucial to behavior and longevity.
Roland BP; Stuchul KA; Larsen SB; Amrich CG; Vandemark AP; Celotto AM; Palladino MJ
J Cell Sci; 2013 Jul; 126(Pt 14):3151-8. PubMed ID: 23641070
[TBL] [Abstract][Full Text] [Related]
11. Triosephosphate isomerase deficiency: biochemical and molecular genetic analysis for prenatal diagnosis.
Pekrun A; Neubauer BA; Eber SW; Lakomek M; Seidel H; Schröter W
Clin Genet; 1995 Apr; 47(4):175-9. PubMed ID: 7628118
[TBL] [Abstract][Full Text] [Related]
12. Differential effects on enzyme stability and kinetic parameters of mutants related to human triosephosphate isomerase deficiency.
Cabrera N; Torres-Larios A; García-Torres I; Enríquez-Flores S; Perez-Montfort R
Biochim Biophys Acta Gen Subj; 2018 Jun; 1862(6):1401-1409. PubMed ID: 29571745
[TBL] [Abstract][Full Text] [Related]
13. Distinct behavior of mutant triosephosphate isomerase in hemolysate and in isolated form: molecular basis of enzyme deficiency.
Orosz F; Oláh J; Alvarez M; Keseru GM; Szabó B; Wágner G; Kovári Z; Horányi M; Baróti K; Martial JA; Hollán S; Ovádi J
Blood; 2001 Nov; 98(10):3106-12. PubMed ID: 11698297
[TBL] [Abstract][Full Text] [Related]
14. Low catalytic activity is insufficient to induce disease pathology in triosephosphate isomerase deficiency.
Segal J; Mülleder M; Krüger A; Adler T; Scholze-Wittler M; Becker L; Calzada-Wack J; Garrett L; Hölter SM; Rathkolb B; Rozman J; Racz I; Fischer R; Busch DH; Neff F; Klingenspor M; Klopstock T; Grüning NM; Michel S; Lukaszewska-McGreal B; Voigt I; Hartmann L; Timmermann B; Lehrach H; Wolf E; Wurst W; Gailus-Durner V; Fuchs H; H de Angelis M; Schrewe H; Yuneva M; Ralser M
J Inherit Metab Dis; 2019 Sep; 42(5):839-849. PubMed ID: 31111503
[TBL] [Abstract][Full Text] [Related]
15. Molecular analysis of a series of alleles in humans with reduced activity at the triosephosphate isomerase locus.
Watanabe M; Zingg BC; Mohrenweiser HW
Am J Hum Genet; 1996 Feb; 58(2):308-16. PubMed ID: 8571957
[TBL] [Abstract][Full Text] [Related]
16. Triose phosphate isomerase deficiency: prenatal diagnosis.
Clark AC; Szobolotzky MA
J Pediatr; 1985 Mar; 106(3):417-20. PubMed ID: 3973779
[TBL] [Abstract][Full Text] [Related]
17. The feasibility of replacement therapy for inherited disorder of glycolysis: triosephosphate isomerase deficiency (review).
Ationu A; Humphries A
Int J Mol Med; 1998 Dec; 2(6):701-4. PubMed ID: 9850739
[TBL] [Abstract][Full Text] [Related]
18. Triose phosphate isomerase deficiency is caused by altered dimerization--not catalytic inactivity--of the mutant enzymes.
Ralser M; Heeren G; Breitenbach M; Lehrach H; Krobitsch S
PLoS One; 2006 Dec; 1(1):e30. PubMed ID: 17183658
[TBL] [Abstract][Full Text] [Related]
19. Generation and analysis of TPI deficiency zebrafish model.
Sun P; Li Y; Liu F; Wang L
Yi Chuan; 2024 Mar; 46(3):232-241. PubMed ID: 38632101
[TBL] [Abstract][Full Text] [Related]
20. In silico prediction of the effects of mutations in the human triose phosphate isomerase gene: Towards a predictive framework for TPI deficiency.
Oliver C; Timson DJ
Eur J Med Genet; 2017 Jun; 60(6):289-298. PubMed ID: 28341520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
